Vladimir Coric, MD, Associate Clinical Professor of Psychiatry and Chief Executive Officer of Biohaven Pharmaceutical Holding Company, has been named Ernst and Young Entrepreneur of the Year for the New York region.
The awards program recognizes entrepreneurs who are excelling in areas such as innovation, financial performance, and personal commitment to their businesses and communities, according to a press release issued by Biohaven. Coric was selected for the award by a panel of independent judges.
“I am honored to be named Entrepreneur of the Year award winner in New York,” Coric said in a statement. “This distinction reflects the incredible team we have at Biohaven and our commitment to developing treatments for patients with a severe unmet need.”
Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders. It has combined internal development and research with intellectual property licensed from several companies and institutions.
Coric, a graduate of the Yale Psychiatry Residency Program and President of the Yale Psychiatry Alumni Association, is now eligible for consideration for the Ernst and Young Entrepreneur of the Year National competition. Award winners will be announced in November.
Now in its 32nd year, the award program has expanded to recognize business leaders in more than 145 cities and more than 60 countries.